Carbohydrate-induced secretion of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1

Journal of Diabetes Investigation

Volumn 7, Issue , 2016, Pages 27-32

  Seino, Yusuke ^a   Maekawa, Ryuya ^a   Ogata, Hidetada ^a   Hayashi, Yoshitaka ^b  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

Author keywords

Carbohydrates; Glucagon like peptide 1; Glucose dependent insulinotropic polypeptide

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; FRUCTOSE; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; GLUCOSE TRANSPORTER 5; MONOSACCHARIDE; SODIUM GLUCOSE COTRANSPORTER 1; SWEETENING AGENT; CARBOHYDRATE DIET; INCRETIN;

ARTICLE; ENTEROENDOCRINE CELL; HORMONE RELEASE; HUMAN; K-CELL; L-CELL; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REGULATORY MECHANISM; TASTE BUD; ANIMAL; CARBOHYDRATE DIET; METABOLISM; MOUSE; PANCREAS ISLET; SECRETION (PROCESS);

ANIMALS; DIETARY CARBOHYDRATES; ENTEROENDOCRINE CELLS; FRUCTOSE; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE; GLUCOSE TRANSPORTER TYPE 5; HUMANS; INCRETINS; ISLETS OF LANGERHANS; KATP CHANNELS; MICE; SODIUM-GLUCOSE TRANSPORTER 1;

EID: 84961266473     PISSN: 20401116     EISSN: 20401124     Source Type: Journal    
DOI: 10.1111/jdi.12449     Document Type: Article

References (50)

1. Baggio LL, Drucker DJ. Biology of incretins: GLP-1 and GIP. Gastroenterology 2007; 132: 2131-2157.
2. Seino Y, Yabe D. Glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1: incretin actions beyond the pancreas. J Diabetes Investig 2013; 4: 108-130.
3. Herrmann C, Göke R, Richter G, et al. Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients. Digestion 1995; 56: 117-126.
4. Rocca AS, Brubaker PL. Role of the vagus nerve in mediating proximal nutrient-induced glucagon-like peptide-1 secretion. Endocrinology 1999; 140: 1687-1694.
5. Cataland S, Crockett SE, Brown JC, et al. Gastric inhibitory polypeptide (GIP) stimulation by oral glucose in man. J Clin Endocrinol Metab 1974; 39: 223-228.
6. Sakamoto E, Seino Y, Fukami A, et al. Ingestion of a moderate high-sucrose diet results in glucose intolerance with reduced liver glucokinase activity and impaired glucagon-like peptide-1 secretion. J Diabetes Investig 2012; 3: 432-440.
7. Fukami A, Seino Y, Ozaki N, et al. Ectopic expression of GIP in pancreatic β-cells maintains enhanced insulin secretion in mice with complete absence of proglucagon-derived peptides. Diabetes 2013; 62: 510-518.
8. Margolskee RF, Dyer J, Kokrashvili Z, et al. T1R3 and gustducin in gut sense sugars to regulate expression of Na+-glucose cotransporter 1. Proc Natl Acad Sci U S A 2007; 104: 15075-15080.
9. Lindemann B. Receptors and transduction in taste. Nature 2001; 413: 219-225.
10. Ogata H, Seino Y, Harada N, et al. KATP channel as well as SGLT1 participates in GIP secretion in the diabetic state. J Endocrinol 2014; 222: 191-200.
11. Fujita Y, Wideman RD, Speck M, et al. Incretin release from gut is acutely enhanced by sugar but not by sweeteners in vivo. Am J Physiol Endocrinol Metab 2009; 296: E473-E479.
12. Ma J, Bellon M, Wishart JM, et al. Effect of the artificial sweetener, sucralose, on gastric emptying and incretin hormone release in healthy subjects. Am J Physiol Gastrointest Liver Physiol 2009; 296: G735-G739.
13. Jang H, Kokrashvili Z, Theodorakis MJ, et al. Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1. Proc Natl Acad Sci U S A 2007; 104: 15069-15074.
14. Parker HE, Habib AM, Rogers GJ, et al. Nutrient-dependent secretion of glucose-dependent insulinotropic polypeptide from primary murine K cells. Diabetologia 2009; 52: 289-298.
15. Reimann F, Habib AM, Tolhurst G, et al. Glucose sensing in L cells: a primary cell study. Cell Metab 2008; 8: 532-539.
16. Kuhre RE, Frost CR, Svendsen B, et al. Molecular mechanisms of glucose-stimulated GLP-1 secretion from perfused rat small intestine. Diabetes 2015; 64: 370-382.
17. Seino Y, Ogata H, Maekawa R, et al. Fructose induces glucose-dependent insulinotropic polypeptide, glucagon-like peptide-1 and insulin secretion: role of adenosine triphosphate-sensitive K + channels. J Diabetes Investig 2015; 6: 522-526.
18. Kuhre RE, Gribble FM, Hartmann B, et al. Fructose stimulates GLP-1 but not GIP secretion in mice, rats, and humans. Am J Physiol Gastrointest Liver Physiol 2014; 306: G622-G630.
19. Sirinek KR, Levine BA, O'Dorisio TM, et al. Gastric inhibitory polypeptide (GIP) release by actively transported, structurally similar carbohydrates. Proc Soc Exp Biol Med 1983; 173: 379-385. Available from: http://www.ncbi.nlm.nih.gov/pubmed/6867011.
20. Flatt PR, Kwasowski P, Bailey CJ. Stimulation of gastric inhibitory polypeptide release in ob/ob mice by oral administration of sugars and their analogues. J Nutr 1989; 119: 1300-1303. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2795243.
21. Gribble FM, Williams L, Simpson AK, et al. A novel glucose-sensing mechanism contributing to glucagon-like peptide-1 secretion from the GLUTag cell line. Diabetes 2003; 52: 1147-1154. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12716745.
22. Kyriazis GA, Soundarapandian MM, Tyrberg B. Sweet taste receptor signaling in beta cells mediates fructose-induced potentiation of glucose-stimulated insulin secretion. Proc Natl Acad Sci U S A 2012; 109: E524-E532.
23. Ferraris RP. Dietary and developmental regulation of intestinal sugar transport. Biochem J 2001(Pt 2); 360: 265-276. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1222226&tool=pmcentrez&rendertype=abstract.
24. Yoshikawa T, Inoue R, Matsumoto M, et al. Comparative expression of hexose transporters (SGLT1, GLUT1, GLUT2 and GLUT5) throughout the mouse gastrointestinal tract. Histochem Cell Biol 2011; 135: 183-194.
25. Damholt AB, Kofod H, Buchan AM. Immunocytochemical evidence for a paracrine interaction between GIP and GLP-1-producing cells in canine small intestine. Cell Tissue Res 1999; 298: 287-293. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10571117.
26. Parker HE, Adriaenssens A, Rogers G, et al. Predominant role of active versus facilitative glucose transport for glucagon-like peptide-1 secretion. Diabetologia 2012; 55(9): 2445-55. doi:10.1007/s00125-012-2585-2.
27. Moriya R, Shirakura T, Ito J, et al. Activation of sodium-glucose cotransporter 1 ameliorates hyperglycemia by mediating incretin secretion in mice. Am J Physiol Endocrinol Metab 2009; 297: E1358-E1365.
28. Gorboulev V, Schürmann A, Vallon V, et al. Na(+)-d-glucose cotransporter SGLT1 is pivotal for intestinal glucose absorption and glucose-dependent incretin secretion. Diabetes 2012; 61: 187-196.
29. Powell DR, Smith M, Greer J, et al. LX4211 increases serum glucagon-like peptide 1 and peptide YY levels by reducing sodium/glucose cotransporter 1 (SGLT1)-mediated absorption of intestinal glucose. J Pharmacol Exp Ther 2013; 345: 250-259.
30. Ganda OP, Soeldner JS, Gleason RE, et al. Metabolic effects of glucose, mannose, galactose, and fructose in man. J Clin Endocrinol Metab 1979; 49: 616-622. Available from: http://www.ncbi.nlm.nih.gov/pubmed/479351.
31. Ritzel U, Fromme A, Ottleben M, et al. Release of glucagon-like peptide-1 (GLP-1) by carbohydrates in the perfused rat ileum. Acta Diabetol 1997; 34: 18-21. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9134052.
32. El-Ouaghlidi A, Rehring E, Holst JJ, et al. The dipeptidyl peptidase 4 inhibitor vildagliptin does not accentuate glibenclamide-induced hypoglycemia but reduces glucose-induced glucagon-like peptide 1 and gastric inhibitory polypeptide secretion. J Clin Endocrinol Metab 2007; 92: 4165-4171.
33. Stephens JW, Bodvarsdottir TB, Wareham K, et al. Effects of short-term therapy with glibenclamide and repaglinide on incretin hormones and oxidative damage associated with postprandial hyperglycaemia in people with type 2 diabetes mellitus. Diabetes Res Clin Pract 2011; 94: 199-206.
34. Pearson ER, Flechtner I, Njølstad PR, et al. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med 2006; 355: 467-477.
35. Murphy R, Tura A, Clark PM, et al. Glucokinase, the pancreatic glucose sensor, is not the gut glucose sensor. Diabetologia 2009; 52: 154-159.
36. Irwin N, Francis JM, Flatt PR. Insulin modulates glucose-dependent insulinotropic polypeptide (GIP) secretion from enteroendocrine K cells in rats. Biol Chem 2011; 392: 909-918.
37. Mace OJ, Schindler M, Patel S. The regulation of K- and L-cell activity by GLUT2 and the calcium-sensing receptor CasR in rat small intestine. J Physiol 2012; 590(Pt 12): 2917-2936.
38. Cani PD, Holst JJ, Drucker DJ, et al. GLUT2 and the incretin receptors are involved in glucose-induced incretin secretion. Mol Cell Endocrinol 2007; 276: 18-23.
39. Geraedts MC, Takahashi T, Vigues S, et al. Transformation of postingestive glucose responses after deletion of sweet taste receptor subunits or gastric bypass surgery. Am J Physiol Endocrinol Metab 2012; 303: E464-E474.
40. Miki T, Nagashima K, Tashiro F, et al. Defective insulin secretion and enhanced insulin action in KATP channel-deficient mice. Proc Natl Acad Sci U S A 1998; 95: 10402-10406. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=27906&tool=pmcentrez&rendertype=abstract.
41. Miki T, Minami K, Shinozaki H, et al. Distinct effects of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 on insulin secretion and gut motility. Diabetes 2005; 54: 1056-1063. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15793244.
42. Lee EY, Kaneko S, Jutabha P, et al. Distinct action of the -glucosidase inhibitor miglitol on SGLT3, enteroendocrine cells, and GLP1 secretion. J Endocrinol 2014; 224: 205-214.
43. Prasadan K, Koizumi M, Tulachan S, et al. The expression and function of glucose-dependent insulinotropic polypeptide in the embryonic mouse pancreas. Diabetes 2011; 60: 548-554.
44. Fujita Y, Wideman RD, Asadi A, et al. Glucose-dependent insulinotropic polypeptide is expressed in pancreatic islet alpha-cells and promotes insulin secretion. Gastroenterology 2010; 138: 1966-1975.
45. Hayashi Y, Yamamoto M, Mizoguchi H, et al. Mice deficient for glucagon gene-derived peptides display normoglycemia and hyperplasia of islet (alpha)-cells but not of intestinal L-cells. Mol Endocrinol 2009; 23: 1990-1999.
46. Hayashi Y. Metabolic impact of glucagon deficiency. Diabetes Obes Metab 2011; 13(Suppl. 1): 151-157.
47. Ellingsgaard H, Hauselmann I, Schuler B, et al. Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells. Nat Med 2011; 17: 1481-1489.
48. Nie Y, Nakashima M, Brubaker PL, et al. Regulation of pancreatic PC1 and PC2 associated with increased glucagon-like peptide 1 in diabetic rats. J Clin Invest 2000; 105: 955-965.
49. Omar BA, Liehua L, Yamada Y, et al. Dipeptidyl peptidase 4 (DPP-4) is expressed in mouse and human islets and its activity is decreased in human islets from individuals with type 2 diabetes. Diabetologia 2014; 57: 1876-1883.
50. Bonner C, Kerr-Conte J, Gmyr V, et al. Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion. Nat Med 2015; 21: 512-517.